Explore how we translate our research into real-world impact success stories
Pre-Clinical Lead of ADVANTAGE visceral pain Advanced Pain Discovery Platform consortium
"Prof. Ewan St. John Smith is the Pre-Clinical Lead on the ADVANTAGE visceral pain Advanced Pain Discovery Platform consortium that links up basic scientists, clinicians, charities and patients to enhance understanding of what drives visceral pains."
Collaborations with industry - GSK and Sosei-Heptares
Work in the Bulmer lab supported by funding from GlaxoSmithKline and Sosei-Heptares seeks to understand the utility of GPR35 agonists as treatments of pain in IBS patients.
Co-founder of SpyBiotech
"Having established collaborations with some great academic colleagues [...] it seemed like starting a company was the best way to take the science forward. Together we founded SpyBiotech in 2017, with various of our former lab members as the first scientists.
Industry Collaboration
Dr Paul Miller is involved in three separate antibody design projects to target ion channels and improve biodistribution, for example, brain penetration, in collaboration with Astra Zeneca. Dr Paul Miller also supports small molecule drug design projects through the engineering of ion channel scaffolds, in collaboration with F. Hoffmann-La Roche AG.
Co-founder of Adrestia Therapeutics
Dr Delphine Larrieu has a strong interest in translational research. Her lab is interested in exploiting the principle of "synthetic rescue" to restore the biological balance in rare premature ageing syndromes (progeria). In 2020, she co-founded Adrestia Therapeutics together with Prof. Steve Jackson, whose aim of rescuing health from genetic diseases through synthetic rescue, was directly inspired by her work.
Delphine is also a scientific advisor for Shift Bioscience, a company based on the biomedical campus in Cambridge, and whose mission is to discover new cellular rejuvenation pathways.
AstraZeneca, GSK and Beiersdorf
Ewan's group has a range of industrial funding, having received support from AstraZeneca, GSK and Beiersdorf.
Ewan is also the Pre-Clinical Lead of ADVANTAGE visceral pain Advanced Pain Discovery Platform consortium
"Prof. Ewan St. John Smith is the Pre-Clinical Lead on the ADVANTAGE visceral pain Advanced Pain Discovery Platform consortium that links up basic scientists, clinicians, charities and patients to enhance understanding of what drives visceral pains."
Collaboration with AstraZeneca
The Wilson laboratory works in collaboration with Astra Zeneca to forward the development of a novel modified
mRNA cardiac regenerative therapeutic that drives endogenous healing.